Cladribine

ATC L04AA40 · 11 markets · 51 records

Cladribine 11 markets · 51 records Forms

AU 16 records · 5 strengths

  • 10 mgtabletCLADRITABCLADRITAB cladribine 10mg tablet blister pack、Mavenclad、MAVENCLAD cladribine 10mg tablet blister pack also in US·GB·CA +3 unknown
  • 10 mg/10 mLinjectionLEUSTATIN also in GB·ES·CN
  • 10 mg/5 mLinjectionLITAK also in GB
  • 2 mg/mLinjectionLITAK cladribine 10mg/5mL injection vial unknown

Records without a stated strength · 1 CLADRITAB、LEUSTATIN、LITAK、Mavenclad +1

US 7 records · 2 strengths

  • 10 mgtabletMavenclad__no_trade__ also in AU·GB·CA +3
  • 1 mginjectionNo trade name

GB 5 records · 3 strengths

  • 10 mgtabletMavenclad__no_trade__ also in AU·US·CA +3
  • 10 mg/10 mLinjectionLeustat 10mg/10ml solution for infusion vials also in AU·ES·CN
  • 10 mg/5 mLinjectionLitak 10mg/5ml solution for injection vials also in AU

CA 5 records · 2 strengths

  • 10 mgtabletAPO-CLADRIBINEAURO-CLADRIBINE、Mavenclad also in AU·US·GB +3
  • 1 mgliquidCladribine

ES 4 records · 3 strengths

EU 3 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

    Records without a stated strength · 1 LITAK、Mavenclad、Movectro

    CN 2 records · 1 strengths

    • 10 mg/10 mLinjection艾博定克拉屈滨__mah__:四川汇宇制药股份有限公司 also in AU·GB·ES

    TW 2 records · 2 strengths

    Records without a stated strength · 1 LEUSTATIN、祿斯得停注射劑

    SG 1 records · 1 strengths

    HK 1 records · 1 strengths

      Records without a stated strength · 1 Mavenclad

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.